Literature DB >> 21584741

Central pontine myelinolysis presented after prophylactic cranial irradiation in small cell lung cancer.

Yoon-Sik Jo1, Sang-Don Han, Sang-Jun Na.   

Abstract

Prophylactic cranial irradiation (PCI) should now be considered as a part of the standard treatment of patients with small cell lung cancer (SCLC) in complete remission. The PCI has been offered in SCLC to reduce the incidence of brain metastasis and increase survival. The complications of PCI were reported brain necrosis, seizure or dementia. The complications were more frequent when chemotherapy was given at the time of cranial irradiation, or large radiation fraction size was employed. It is established that the pathophysiological reaction to irradiation in the normal brain tissue is necrosis, demyelinization, and diffuse changes due to wall thickening of the vascular structures. However, central pontine myelinolysis (CPM) of low dose irradiation like PCI is very rare. We report a patient with the classical syndrome of CPM following PCI for SCLC. The diagnosis was supported by typical features on magnetic resonance imaging.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21584741     DOI: 10.1007/s10072-011-0601-9

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  17 in total

Review 1.  Neurological changes following radiation therapy for head and neck tumours.

Authors:  V F H Chong; J B K Khoo; L L Chan; H Rumpel
Journal:  Eur J Radiol       Date:  2002-11       Impact factor: 3.528

Review 2.  Myelinolysis after correction of hyponatremia.

Authors:  R Laureno; B I Karp
Journal:  Ann Intern Med       Date:  1997-01-01       Impact factor: 25.391

3.  Central pontine myelinolysis secondary to frequent and rapid shifts in plasma glucose in a diabetic haemodialysis patient.

Authors:  N Esforzado; E Poch; A Cases; C Cardenal; J López-Pedret; L Revert
Journal:  Nephrol Dial Transplant       Date:  1993       Impact factor: 5.992

4.  Organic osmolytes in acute hyponatremia.

Authors:  R H Sterns; J Baer; S Ebersol; D Thomas; J W Lohr; D E Kamm
Journal:  Am J Physiol       Date:  1993-05

5.  Disruption of the blood-brain barrier as the primary effect of CNS irradiation.

Authors:  P Rubin; D M Gash; J T Hansen; D F Nelson; J P Williams
Journal:  Radiother Oncol       Date:  1994-04       Impact factor: 6.280

6.  Late neurological complications after prophylactic cranial irradiation in patients with small-cell lung cancer: the Toronto experience.

Authors:  M Lishner; R Feld; D G Payne; U Sagman; J P Sculier; J F Pringle; J L Yeoh; W K Evans; F A Shepherd; E Maki
Journal:  J Clin Oncol       Date:  1990-02       Impact factor: 44.544

7.  Diffusion tensor imaging screening of radiation-induced changes in the white matter after prophylactic cranial irradiation of patients with small cell lung cancer: first results of a prospective study.

Authors:  T Welzel; A Niethammer; U Mende; S Heiland; F Wenz; J Debus; R Krempien
Journal:  AJNR Am J Neuroradiol       Date:  2007-11-01       Impact factor: 3.825

8.  Radiation effects on cerebral white matter: MR evaluation.

Authors:  J S Tsuruda; K E Kortman; W G Bradley; D C Wheeler; W Van Dalsem; T P Bradley
Journal:  AJR Am J Roentgenol       Date:  1987-07       Impact factor: 3.959

Review 9.  Lateral pontine and extrapontine myelinolysis associated with hypernatremia and hyperglycemia.

Authors:  R D McComb; R F Pfeiffer; J H Casey; G Wolcott; D J Till
Journal:  Clin Neuropathol       Date:  1989 Nov-Dec       Impact factor: 1.368

Review 10.  Changes in blood-brain barrier permeability induced by radiotherapy: implications for timing of chemotherapy? (Review).

Authors:  Marco van Vulpen; Henk B Kal; Martin J B Taphoorn; Sherif Y El-Sharouni
Journal:  Oncol Rep       Date:  2002 Jul-Aug       Impact factor: 3.906

View more
  1 in total

1.  The magnetic resonance spectroscopy findings of extrapontine myelinolysis in a patient with acute lymphoblastic leukemia.

Authors:  Hulya Aslan; Fuldem Y Donmez; O Koray Hekimoglu; Huseyin G Tore
Journal:  Neurol Sci       Date:  2011-08-16       Impact factor: 3.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.